Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
88.98
+1.73 (1.98%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Spyre Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
125
Market Cap
7.85B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 886.00K | -1.44M | -61.96% |
| Dec 31, 2022 | 2.33M | -16.41M | -87.57% |
| Dec 31, 2021 | 18.74M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Caris Life Sciences | 989.61M |
| TG Therapeutics | 799.54M |
| Mirum Pharmaceuticals | 618.07M |
| Protagonist Therapeutics | 281.99M |
| Rhythm Pharmaceuticals | 239.92M |
| ImmunityBio | 165.79M |
| CG Oncology | 6.23M |
SYRE News
- 12 hours ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire
- 1 day ago - Spyre Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 9 days ago - Spyre Therapeutics falls -13.2% - TheFly
- 9 days ago - Spyre Therapeutics falls -11.6% - TheFly
- 9 days ago - Spyre Therapeutics price target lowered to $123 from $130 at Wedbush - TheFly
- 9 days ago - Spyre Therapeutics price target lowered to $121 from $132 at BTIG - TheFly
- 9 days ago - Spyre Therapeutics price target lowered to $127 from $135 at Deutsche Bank - TheFly
- 10 days ago - Spyre Therapeutics Stock (SYRE) Tumbles 14% in After-Hours – Here’s What Spooked Investors - TipRanks